Trial · NCT03391882
Adverse events52
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 52
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nausea | Gastrointestinal disorders | Part A Dose Titration: APL (APL-130277) | 32 | 102 | 53 |
| other | Nausea | Gastrointestinal disorders | Part A Dose Titration: SC (Subcutaneous Apomorphine) | 22 | 97 | 31 |
| other | Nausea | Gastrointestinal disorders | Part B Treatment: APL (APL-130277) | 10 | 71 | 25 |
| other | Nausea | Gastrointestinal disorders | Part B Treatment: SC (Subcutaneous Apomorphine) | 11 | 70 | 21 |
| other | Fatigue | General disorders | Part A Dose Titration: APL (APL-130277) | 6 | 102 | 6 |
| other | Fatigue | General disorders | Part A Dose Titration: SC (Subcutaneous Apomorphine) | 10 | 97 | 10 |
| other | Fatigue | General disorders | Part B Treatment: APL (APL-130277) | 4 | 71 | 4 |
| other | Fatigue | General disorders | Part B Treatment: SC (Subcutaneous Apomorphine) | 4 | 70 | 5 |
| other | Injection site erythema | General disorders | Part A Dose Titration: APL (APL-130277) | 0 | 102 | 0 |
| other | Injection site erythema | General disorders | Part A Dose Titration: SC (Subcutaneous Apomorphine) | 6 | 97 | 9 |
| other | Injection site erythema | General disorders | Part B Treatment: APL (APL-130277) | 1 | 71 | 1 |
| other | Injection site erythema | General disorders | Part B Treatment: SC (Subcutaneous Apomorphine) | 5 | 70 | 5 |
| other | Injection site haematoma | General disorders | Part A Dose Titration: APL (APL-130277) | 0 | 102 | 0 |
| other | Injection site haematoma | General disorders | Part A Dose Titration: SC (Subcutaneous Apomorphine) | 2 | 97 | 2 |
| other | Injection site haematoma | General disorders | Part B Treatment: APL (APL-130277) | 0 | 71 | 0 |
| other | Injection site haematoma | General disorders | Part B Treatment: SC (Subcutaneous Apomorphine) | 19 | 70 | 23 |
| other | Fall | Injury, poisoning and procedural complications | Part A Dose Titration: APL (APL-130277) | 1 | 102 | 2 |
| other | Fall | Injury, poisoning and procedural complications | Part A Dose Titration: SC (Subcutaneous Apomorphine) | 1 | 97 | 1 |
| other | Fall | Injury, poisoning and procedural complications | Part B Treatment: APL (APL-130277) | 4 | 71 | 5 |
| other | Fall | Injury, poisoning and procedural complications | Part B Treatment: SC (Subcutaneous Apomorphine) | 1 | 70 | 3 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03391882/events